Arena Pharmaceuticals (ARNA) Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track
Tweet Send to a Friend
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
